Articles by Meso Foundation

Good luck at Johns Hopkins, Jadmin!

While the prestigious Johns Hopkins University is gaining a talented new graduate student, we are sadly losing our patient support and research assistant, Jadmin Mostel, this week.
In her year-and-a-half tenure with the Meso Foundation, many of you interacted with Jadmin as she introduced you to support groups, helped you with a travel grant application […]


JUST PUBLISHED: New report outlining progress in mesothelioma treatment in 2017

A new article reviewing progress and advances that occurred in 2017 in the management of pleural mesothelioma was just published in the May 2018 issue of the Journal of Thoracic Oncology.
The publication is the result of collaboration among mesothelioma experts from around the world, including several current and former members of the Mesothelioma Applied Research […]


Can pemetrexed’s (Alimta) effectiveness in mesothelioma treatment be improved?

In 2004, over 14 years ago (!), the FDA approved the first ever (and the last so far) mesothelioma treatment drug – Alimta (pemetrexed) in combination with cisplatin. The treatment is now very much considered standard and for some patients the results are dramatic. Unfortunately, patients and physicians alike are well aware of its limitations. […]


Meet and greet our new communications associate

We are happy to welcome Trey Meehan – our new communications associate – to the Meso Foundation! He joined us earlier this month and will be assisting with the management and development of our online and offline communications.
Trey brings a knowledge of nonprofit and public health communications as well as a desire to serve mission-driven organizations […]


Congress funds congressionally directed DOD funding for FY18 with $80 million

We are excited to report that Congress has funded the congressionally directed Department of Defense (DoD) funding for Fiscal Year 2018 (FY18) with $80 million to support innovative, high-impact cancer research. This is a major increase from last year’s $60 million, $50 million the year before, and $25 million two years prior. The upward trend, in […]